[1]
S. Kelderman, “Ipilimumab in pretreated metastastic uveal melanoma patients. Results of the Dutch Working group on Immunotherapy of Oncology (WIN-O)”, AO, vol. 52, no. 8, pp. 1786–1788, Nov. 2013.